Summary
Vaccinia virus comprises the live vaccine that was used for vaccination against smallpox. Following the eradication of smallpox, vaccinia virus was developed as an expression vector that is now used widely in biological research and vaccine development. In recent years vaccinia virus and other p oxviruses have been found to express a collection of proteins that block parts of the host response to infection. Some of these proteins are secreted from the infected cell where they bind and neutralise host cytokines, chemokines and interferons (IFN). In this paper three such proteins that bind interleukin (IL)-1β, type I IFNs and CC chemokines are described. The study of these immunomodulatory molecules is enhancing our understanding of virus pathogenesis, yielding fundamental information about the immune system, and providing new molecules that have potential application for the treatment of immunological disorders or infectious diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Aguado B, Seltnes IP, Smith GL (1992) Nucleotide sequence of 21.8 kbp of variola major virus strain Harvey and comparison with vaccinia virus. J Gen Virol 73: 2 887–2 902
Alcamí A, Smith GL (1992) A soluble receptor for interleukin-IL-lβ encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell 71: 153–167
Alcamí A, Smith GL (1995) Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity. J Virol 69: 4 633–4 639
Alcamí A, Smith GL (1996) A mechanism for the inhibition of fever by a virus. Proc Natl Acad Sci USA 93: 11029–11034
Alcamí A, Symons JA, Collins PD, Williams TJ, Smith GL (1998) Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus. J Immunol 160: 624–633
Amano H, Ueda Y, Tagaya I (1979) Orthopoxvirus strains defective in surface antigen induction. J Gen Virol 44: 265–269
Antoine G, Scheiflinger F, Dorner F, Falkner FG (1998) The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses. Virology 244: 365–396
Baggiolini M, Dewald B, Moser B (1997) Human chemokines: an update. Annu Rev Immunol 15: 675–705
Baxby D (1981) Jenner’s smallpox vaccine. The riddle of the origin of vaccinia virus. Heinemann, London
Beattie E, Tartaglia J, Paoletti E (1991) Vaccinia-virus encoded eIF-2α homolog abrogates the antiviral effect of interferon. Virology 183: 419–422
Berger EA (1997) HIV entry and tropism: the chemokine receptor connection. AIDS 11: S3–16
Blake NW, Kettle S, Law KM, Gould K, Bastin J, Townsend AR, Smith GL (1995) Vaccinia virus serpins B13R and B22R do not inhibit antigen presentation to class I-restricted cytotoxic T lymphocytes. J Gen Virol 76: 2 393–2 398
Blanchard TJ, Alcamí A, Andrea P, Smith GL (1998) Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine. J Gen Virol 79: 1 159–1 167
Bosworth N, Towers P (1989) Scintillation proximity assay. Nature 341: 167–168
Chang H-W, Watson JC, Jacobs BL (1992) The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. Proc Natl Acad Sci USA 89: 4 825–4 829
Cochran MA, Puckett C, Moss B (1985) In vitro mutagenesis of the promoter region for a vaccinia virus gene: evidence for tandem early and late regulatory signals. J Virol 54: 30–37
Colamonici OR, Domanski P, Sweitzer SM, Larner A, Buller RML (1995) Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon alpha transmembrane signaling. J Biol Chem 270: 15 974–15 978
Collins PD, Marleau S, Griffiths-Johnson DA, Jose PJ, Williams TJ (1995) Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med 182: 1169–1174
Dinarello CA (1996) Biological basis for interleukin-1 in disease. Blood 87: 2 095–2 147
Fenner F, Anderson DA, Arita I, Jezek Z, Ladnyi ID (1988) Smallpox and its eradication. World Health Organisation, Geneva
Goebel SJ, Johnson GP, Perkus ME, Davis SW, Winslow JP, Paoletti E (1990) The complete DNA sequence of vaccinia virus. Virology 179: 247–266
Graham KA, Lalani AS, Macen JL, Ness TL, Barry M, Liu L, Lucas A, Clark-Lewis I, Moyer RW, McFadden G (1997) The Tl/35 kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues. Virology 229: 12–24
Horuk R, Chitnis CE, Darbonne WC, Colby TJ, Rybicki A, Hadley TJ, Miller LH (1993) A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science 261: 1182–1184
Howard ST, Chan YS, Smith GL (1991 ) Vaccinia virus homologues of the Shope fibroma virus inverted terminal repeat proteins and a discontinuous ORF related to the tumor necrosis factor receptor family. Virology 180: 633–647
Jenner E (1798) An enquiry into the causes and effects of variolae vaccinae, a disease discovered in some western countries of England, particularly Gloucestershire, and known by the name of cow pox. Reprinted by Cassell, 1896, London
Kozak W, Zheng H, Conn CA, Soszynski D, vander Ploeg LH, Kluger MJ (1995) Thermal and behavioral effects of lipopolysaccharide and influenza in interleukin-1 beta-deficient mice. Am J Physiol 269: 969–977
Lane JM, Ruben FL, Neff JM, Millar JD (1969) Complications of smallpox vaccination, 1968. National surveillance in the United States. N Engl J Med 281: 1 201–1 208
Liptakova H, Kontsekova E, Alcamí A, Smith GL, Kontsek P (1997) Analysis of an interaction between the soluble vaccinia virus-coded type I interferon (IFN)-receptor and human IFN-alphal and IFN-alpha2. Virology 232: 86–90
Mackett M, Smith GL, Moss B (1982) Vaccinia virus: a selectable eukaryotic cloninig and expression vector. Proc Natl Acad Sci USA 79: 7 415–7 419
Mackett M, Smith GL, Moss B (1984) General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. J Virol 49: 857–864
Massung RF, Liu LI, Qi J, Knight JC, Yuran TE, Kerlavage AR, Parsons JM, Venter JC, Esposito JJ (1994) Analysis of the complete genome of smallpox variola major virus strain Bangladesh-1975. Virology 201: 215–240
McMahan CJ, Slack JL, Mosley B, Cosman D, Lupton SD, Brunton LL, Grubin CE, Wignall JM, Jenkins NA, Branan CI, Copeland NG, Huebner K, Croce CM, Cannizzarro LA, Benjamin D, Dower SK, Spriggs MK, Sims JE (1991) A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J 10: 2821–2 832
Morikawa S, Ueda Y (1993) Characterization of vaccinia surface antigen expressed by recombinant baculovirus. Virology 193: 753–761
Moss B (1996) Poxviridae: the viruses and their replication. In: Fields BN, Knipe DM, Howley PM (eds) Fields Virology. Lippincott-Raven Press, New York, vol 2, pp 2637–2671
Moss B, Winters E, Coopper JA (1981) Deletion of a 9,000-base-pair segment of the vaccinia virus genome that encodes nonessential polypeptides. J Virol 40: 387–395
Mossman K, Nation P, Macen J, Garbutt M, Lucas A, McFadden G (1996) Myxoma virus M-T7, a secreted homolog of the interferon-gamma receptor, is a critical virulence factor for the development of myxomatosis in European rabbits. Virology 215: 17–30
Mossman K, Upton C, Buller RM, McFadden G (1995) Species specificity of ectromelia virus and vaccinia virus interferon-gamma binding proteins. Virology 208: 762–769
Novick D, Cohen B, Rubinstein M (1994) The human interferon a/b receptor: characterization and molecular cloning. Cell 77: 391–400
Panicali D, Paoletti E (1982) Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus. Proc Natl Acad Sci USA 79: 4 927–4 931
Patel AH, Gaffney DF, Subak-Sharpe JH, Stow ND (1990) DNA sequence of the gene encoding a major secreted protein of vaccinia virus, strain Lister. J Gen Virol 71: 2013–2021
Premack BA, Schall TJ (1996) Chemokine receptors: gateways to inflammation and infection. Nature Med 2: 1 174–1 178
Shchelkunov SN, Massung RF, Esposito JJ (1995) Comparison of the genome DNA sequences of Bangladesh-1975 and India-1967 variola viruses. Virus Res 36: 107–118
Smith CA, Smith TD, Smolak PJ, Friend D, Hagen H, Gernart M, Park L, Pickup DJ, Torrance D, Mohler K, Schooley K, Goodwin RG (1997) Poxvirus genomes encode a secreted, soluble protein that preferentially inhibits β chemokine activity yet lacks sequence homology to known chemokine receptors. Virology 236: 316–327
Smith GL, Chan YS (1991 ) Two vaccinia virus proteins structurally related to interleukin-1 receptor and the immunoglobulin superfamily. J Gen Virol 72: 511–518
Smith GL, Mackett M, Moss B (1983) Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen. Nature 302: 490–495
Smith GL, Symons JA, Alcamí A (1998) Poxviruses; interfering with interferon. Semin Virol 8: 409–418
Smith GL, Symons JA, Khanna A, Vanderplasschen A, Alcamí A (1997) Vaccinia virus immune evasion. Immunol Rev 159: 137–154
Spriggs M, Hruby DE, Maliszewski CR, Pickup DJ, Sims JE, Buller RML, Vanslyke J (1992) Vaccinia and cowpox viruses encode a novel secreted interleukin-1 binding protein. Cell 71: 145–152
Symons JA, Alcamí A, Smith GL (1995) Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell 81: 551–560
Ueda Y, Ito M, Tagaya I (1969) A specific surface antigen induced by poxvirus. Virology 38:180-182
Ueda Y, Morikawa S, Matsuura Y (1990) Identification and nucleotide sequence of the gene encoding a surface antigen induced by vaccinia virus. Virology 177: 588–594
Ueda Y, Tagaya I (1973) Induction of skin resistance to vaccinia virus in rabbits by vaccinia-soluble early antigens. J Exp Med 138: 1 033–1 043
Ueda Y, Tagaya I, Amano H, Ito M (1972) Studies on the early antigens induced by vaccinia virus. Virology 49: 794–800
Upton C, Mossman K, McFadden G (1992) Encoding of a homolog of IFN-γreceptor by myxoma virus. Science 258: 1 369–1 372
Uzé G, Lutfalla G, Gresser I (1990) Genetic transfer of α functional human interferon a receptor into mouse cells: cloning and expression of its cDNA. Cell 60: 225–234
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Wien
About this chapter
Cite this chapter
Smith, G.L., Symons, J.A., Alcamí, A. (1999). Immune modulation by proteins secreted from cells infected by vaccinia virus. In: Calisher, C.H., Horzinek, M.C. (eds) 100 Years of Virology. Archives of Virology. Supplementa, vol 15. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6425-9_8
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6425-9_8
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-83360-5
Online ISBN: 978-3-7091-6425-9
eBook Packages: Springer Book Archive